Shannon L. Venance

2.2k total citations
46 papers, 1.3k citations indexed

About

Shannon L. Venance is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Shannon L. Venance has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 18 papers in Molecular Biology and 9 papers in Neurology. Recurrent topics in Shannon L. Venance's work include Genetic Neurodegenerative Diseases (18 papers), Muscle Physiology and Disorders (8 papers) and Ion channel regulation and function (8 papers). Shannon L. Venance is often cited by papers focused on Genetic Neurodegenerative Diseases (18 papers), Muscle Physiology and Disorders (8 papers) and Ion channel regulation and function (8 papers). Shannon L. Venance collaborates with scholars based in Canada, United States and France. Shannon L. Venance's co-authors include Rabi Tawil, Robert C. Griggs, Michael G. Hanna, Stephen C. Cannon, Doreen Fialho, Bertrand Fontaine, Kori A. LaDonna, Richard J.L.F. Lemmers, Baziel G.M. van Engelen and Jessica C. de Greef and has published in prestigious journals such as SHILAP Revista de lepidopterología, Circulation Research and Brain.

In The Last Decade

Shannon L. Venance

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shannon L. Venance Canada 17 928 509 394 202 159 46 1.3k
Sandeep Jayawant United Kingdom 26 584 0.6× 185 0.4× 169 0.4× 713 3.5× 169 1.1× 57 1.7k
Maggie Williams United Kingdom 17 512 0.6× 167 0.3× 237 0.6× 70 0.3× 148 0.9× 52 1.1k
J Stephenson United Kingdom 20 673 0.7× 298 0.6× 102 0.3× 138 0.7× 85 0.5× 63 1.7k
Robert I. Roelofs United States 16 410 0.4× 248 0.5× 74 0.2× 414 2.0× 250 1.6× 29 1.2k
Johanna Schneider Germany 13 769 0.8× 159 0.3× 185 0.5× 32 0.2× 30 0.2× 39 1.3k
David A. Buchner United States 25 725 0.8× 126 0.2× 79 0.2× 36 0.2× 60 0.4× 44 1.4k
Lauren M. Byrne United Kingdom 19 648 0.7× 740 1.5× 29 0.1× 460 2.3× 36 0.2× 44 1.4k
Masami Hirano Japan 18 477 0.5× 130 0.3× 29 0.1× 102 0.5× 148 0.9× 55 1.4k
Hannah R. Elliott United Kingdom 18 1.2k 1.3× 64 0.1× 93 0.2× 32 0.2× 62 0.4× 39 1.7k
Annie Kennedy United States 10 367 0.4× 50 0.1× 86 0.2× 53 0.3× 165 1.0× 23 633

Countries citing papers authored by Shannon L. Venance

Since Specialization
Citations

This map shows the geographic impact of Shannon L. Venance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon L. Venance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon L. Venance more than expected).

Fields of papers citing papers by Shannon L. Venance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon L. Venance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon L. Venance. The network helps show where Shannon L. Venance may publish in the future.

Co-authorship network of co-authors of Shannon L. Venance

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon L. Venance. A scholar is included among the top collaborators of Shannon L. Venance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon L. Venance. Shannon L. Venance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koopman, Wilma J., Kori A. LaDonna, Elizabeth Anne Kinsella, Shannon L. Venance, & Christopher Watling. (2021). Getting airtime: Exploring how patients shape the stories they tell health practitioners. Medical Education. 55(10). 1142–1151. 4 indexed citations
2.
Venance, Shannon L., et al.. (2020). An LGBTQ+ mentorship program enriched the experience of medical students and physician mentors. SHILAP Revista de lepidopterología. 11(6). e159–e162. 16 indexed citations
3.
Venance, Shannon L., et al.. (2020). Western University Schulich School of Medicine & Dentistry. Academic Medicine. 95(9S). S583–S587. 1 indexed citations
4.
Sebok‐Syer, Stefanie S., Mark Goldszmidt, Christopher Watling, et al.. (2019). Using Electronic Health Record Data to Assess Residents’ Clinical Performance in the Workplace: The Good, the Bad, and the Unthinkable. Academic Medicine. 94(6). 853–860. 30 indexed citations
5.
Koopman, Wilma J., et al.. (2017). Survey of Canadian Myotonic Dystrophy Patients’ Access to Computer Technology. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 44(5). 567–571. 2 indexed citations
6.
McCormick, Anna, Alex MacKenzie, Erin O’Ferrall, et al.. (2017). The Canadian Neuromuscular Disease Registry: Connecting patients to national and international research opportunities. Paediatrics & Child Health. 23(1). 20–26. 11 indexed citations
7.
Tarnopolsky, Mark A., Hans Katzberg, Basil J. Petrof, et al.. (2016). Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 43(4). 472–485. 45 indexed citations
8.
LaDonna, Kori A. & Shannon L. Venance. (2015). Picturing the Experience of Living With Myotonic Dystrophy (DM1). Journal of Neuroscience Nursing. 47(5). 285–295. 20 indexed citations
9.
Trivedi, Jaya, Brian N. Bundy, Jeffrey Statland, et al.. (2013). Non-dystrophic myotonia: prospective study of objective and patient reported outcomes. Brain. 136(7). 2189–2200. 76 indexed citations
10.
Campbell, Craig, Simon A. Levin, Victoria Mok Siu, Shannon L. Venance, & Pierre Jacob. (2013). Congenital Myotonic Dystrophy: Canadian Population-Based Surveillance Study. The Journal of Pediatrics. 163(1). 120–125.e3. 45 indexed citations
11.
LaDonna, Kori A. & Shannon L. Venance. (2011). P5.4 Photovoice: Using an innovative qualitative research method to capture the experiences of individuals with myotonic dystrophy (DM1). Neuromuscular Disorders. 21(9-10). 724–725. 1 indexed citations
12.
Greef, Jessica C. de, Richard J.L.F. Lemmers, Pilar Camaño, et al.. (2010). Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology. 75(17). 1548–1554. 117 indexed citations
13.
Matthews, Emma, Doreen Fialho, S. Veronica Tan, et al.. (2009). The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain. 133(1). 9–22. 148 indexed citations
14.
LaDonna, Kori A., et al.. (2007). G.P.15.01 Pilot study to determine the transition needs of adolescents and adults with Duchenne muscular dystrophy. Neuromuscular Disorders. 17(9-10). 864–865. 2 indexed citations
15.
Venance, Shannon L. & Wilma J. Koopman. (2007). G.P.7.12 Living with OPMD. Neuromuscular Disorders. 17(9-10). 809–809. 1 indexed citations
16.
Venance, Shannon L., Barbara E. Herr, & Robert C. Griggs. (2007). Challenges in the Design and Conduct of Therapeutic Trials in Channel Disorders. Neurotherapeutics. 4(2). 199–204. 8 indexed citations
17.
Osborne, Robert J., Stephen Welle, Shannon L. Venance, Charles A. Thornton, & Rabi Tawil. (2006). Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology. 68(8). 569–577. 112 indexed citations
18.
Venance, Shannon L., Stephen C. Cannon, Doreen Fialho, et al.. (2005). The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain. 129(1). 8–17. 228 indexed citations
19.
Venance, Shannon L., Brian M. Bennett, & Stephen C. Pang. (1994). Isoproterenol exerts cyclic AMP independent effects on DNA synthesis in cultured adventitial fibroblasts from spontaneously hypertensive and Wistar–Kyoto rats. Canadian Journal of Physiology and Pharmacology. 72(10). 1208–1214. 1 indexed citations
20.
Pang, Stephen C. & Shannon L. Venance. (1992). Cultured smooth muscle approach in the study of hypertension. Canadian Journal of Physiology and Pharmacology. 70(4). 573–579. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandeep Jayawant Breakdown of academic impact, for papers by Maggie Williams Breakdown of academic impact, for papers by J Stephenson Breakdown of academic impact, for papers by Robert I. Roelofs Breakdown of academic impact, for papers by Johanna Schneider Breakdown of academic impact, for papers by David A. Buchner Breakdown of academic impact, for papers by Lauren M. Byrne Breakdown of academic impact, for papers by Masami Hirano Breakdown of academic impact, for papers by Hannah R. Elliott Breakdown of academic impact, for papers by Annie Kennedy
Rankless by CCL
2026